Clinical Trial Site Activation Operational Readiness Checklist
Verify regulatory binders, investigational product storage, and staff certifications prior to issuing site activation.
Deploy this checklist during final site initiation visits to guarantee regulatory compliance and operational readiness. It ensures clinical sites meet all GCP and protocol requirements before screening their first subject.
Role: Senior Clinical Operations Director specializing in global clinical trial execution and GCP compliance.
Context
- Protocol identifier: {{protocol_id}}
- Clinical phase: {{study_phase}}
- Investigational drug or device: {{investigational_product_type}}
- Clinical site and institution: {{site_name}}
- Principal Investigator: {{principal_investigator}}
- Governing regulatory bodies: {{regulatory_authority}}
Task
Generate a comprehensive, phase-specific site activation readiness checklist to evaluate and approve {{site_name}} under {{protocol_id}}, confirming operational, logistical, and regulatory integrity before authorizing first patient enrollment.
Method
- Audit the Essential Document Binder (eTMF) for complete IRB/IEC approvals, financial disclosures, and signed Form FDA 1572 or local equivalents for {{regulatory_authority}}.
- Verify the Delegation of Authority log against current CVs, medical licenses, and GCP training certificates for {{principal_investigator}} and site staff.
- Validate pharmacy readiness for {{investigational_product_type}}, including temperature monitoring calibration, quarantine zones, and unblinded pharmacist access.
- Confirm Interactive Response Technology (IRT/RTSM) and Electronic Data Capture (EDC) user access provisioning and role-based privilege testing.
- Inspect site-specific laboratory handling workflows, including centrifuge calibration, -80C freezer backup power, and pre-printed sample shipping manifests.
- Review protocol-specific adverse event escalation pathways and emergency unblinding operational procedures.
- Establish a formal go/no-go activation criteria sign-off block with explicit milestone dependencies.
Constraints
- Every checklist item MUST include a verification criterion, required evidence artifact, and role responsible.
- Items MUST NOT use ambiguous status indicators; strictly use [ ] Pass, [ ] Action Required, or [ ] Not Applicable.
- Include explicit regulatory citation references relevant to {{regulatory_authority}}.
- Maintain focus on operational execution rather than clinical pharmacology.
Output format
Provide a structured checklist organized into five sequential sections: (1) Regulatory & Ethics Documentation, (2) Staff Delegation & Training, (3) Investigational Product & Pharmacy Logistics, (4) Lab & Diagnostic Facilities, and (5) Systems Access & Activation Sign-Off. Total item count must be between 20 and 30 discrete checklist items.
Self-review
- Are all 6 context variables integrated logically into the checklist criteria?
- Is every item actionable with a concrete evidentiary standard?
- Does the activation sign-off section include clear go/no-go blocker criteria?
Explicit role, a named task, and discrete steps the model can follow.
Background, inputs and variables the model needs before it starts.
Hard boundaries — what the model must and must not do.
A named, field-level shape for the response.
Ordered work items that force analysis before an answer.
Length and structure that travel across frontier models.
Signal density — instruction weight without padding.
Documented variables so the scaffold adapts to new inputs.
Quality bar, assumptions and behaviour when inputs are thin.
How much real usage the template has behind it.